Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2009 1
2012 1
2013 1
2016 2
2017 2
2018 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, Mannens MM, Wilde AA, Ackerman MJ. Medeiros-Domingo A, et al. J Am Coll Cardiol. 2009 Nov 24;54(22):2065-74. doi: 10.1016/j.jacc.2009.08.022. J Am Coll Cardiol. 2009. PMID: 19926015 Free PMC article.
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Associated With Ryanodine Receptor (RyR2) Gene Mutations　- Long-Term Prognosis After Initiation of Medical Treatment.
Kawata H, Ohno S, Aiba T, Sakaguchi H, Miyazaki A, Sumitomo N, Kamakura T, Nakajima I, Inoue YY, Miyamoto K, Okamura H, Noda T, Kusano K, Kamakura S, Miyamoto Y, Shiraishi I, Horie M, Shimizu W. Kawata H, et al. Circ J. 2016 Aug 25;80(9):1907-15. doi: 10.1253/circj.CJ-16-0250. Epub 2016 Jul 22. Circ J. 2016. PMID: 27452199 Free article.
Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia.
Wangüemert Pérez F, Hernández Afonso JS, Groba Marco MDV, Caballero Dorta E, Álvarez Acosta L, Campuzano Larrea O, Pérez G, Brugada Terradellas J, Brugada Terradellas R. Wangüemert Pérez F, et al. Rev Esp Cardiol (Engl Ed). 2018 Mar;71(3):185-191. doi: 10.1016/j.rec.2017.04.032. Epub 2017 Aug 5. Rev Esp Cardiol (Engl Ed). 2018. PMID: 28789916 English, Spanish.
Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2.
Xiong J, Liu X, Gong Y, Zhang P, Qiang S, Zhao Q, Guo R, Qian Y, Wang L, Zhu L, Wang R, Hao Z, Wen H, Zhang J, Tang K, Zang WF, Yuchi Z, Chen H, Chen SRW, Zheng W, Wang SQ, Xu YW, Liu Z. Xiong J, et al. J Mol Cell Cardiol. 2018 Apr;117:26-35. doi: 10.1016/j.yjmcc.2018.02.014. Epub 2018 Mar 2. J Mol Cell Cardiol. 2018. PMID: 29477366